
Executive Summary: As of mid-2025, data from the Rapacke Law Group and WIPO confirms a structural shift in the global intellectual property landscape: China now accounts for approximately 70% of all artificial intelligence patent applications worldwide. However, raw volume metrics disguise a complex reality of low grant rates and subsidy-driven filing behaviors that create specific, high-cost liabilities for Western IP practices.
The accumulation of approximately 300,000 AI-related applications in the 2024–2025 cycle is not an accidental market phenomenon. It is the direct output of the "14th Five-Year Plan," which explicitly incentivized patent metrics as a proxy for innovation. Unlike the US market, where filings are primarily driven by corporate R&D ROI (e.g., Alphabet, Microsoft), a significant percentage of Chinese volume originates from academic institutions and state-affiliated laboratories.
For IP strategy consultants, this necessitates a bifurcation in how we analyze global patent landscapes:
The critical metric for patent attorneys is not the filing number, but the allowance rate. Current data indicates a sharp divergence in asset viability. While China dominates GenAI filings by a factor of 6:1 compared to the US, the grant rate for these AI patents stands at approximately 32%. This contrasts with a general patent grant rate of ~55% within the CNIPA (China National Intellectual Property Administration).
The 68% rejection/abandonment rate suggests a "file first, refine later" approach, heavily influenced by government subsidies that reward the act of filing rather than the issuance of the grant. Furthermore, citation analysis reveals that US AI patents are cited ~7x more frequently than their Chinese counterparts, indicating that while China owns the volume, the US retains the foundational technical influence.
However, dismissed applications still pose a significant threat. They constitute prior art. A rejected Chinese application, published 18 months after filing, effectively burns the novelty for subsequent global filings, regardless of whether the Chinese applicant ever secures the right.
For IP Managers and Outside Counsel, the surge in volume creates a tangible operational drag. The primary bottleneck is the "Needle in a Haystack" scenario regarding Freedom-to-Operate (FTO) searches.
To manage this influx, CNIPA has expanded its examination workforce to over 16,000 and integrated AI-assisted examination systems. Their stated goal is a 15-month pendency period by late 2025. This creates an asymmetry in capabilities: the patent office is using LLMs to classify and reject patents, while many law firms rely on legacy keyword search tools.
In response to these market conditions, firms must adapt their prosecution and litigation strategies:
Conclusion: China’s 70% share represents a logistical challenge rather than a purely competitive one. The risk is not necessarily that Chinese firms possess superior technology, but that they have successfully weaponized the patent system’s administrative burden. Success in 2025 requires superior filtering mechanisms and a ruthlessly efficient search strategy.

IP News
Recent data indicates a 41% burnout rate among legal professionals, posing a systemic risk to work product quality. This analysis explores the viability of Large Language Models (LLMs) not as creative tools, but as mechanisms to reduce low-value cognitive load in IP workflows.

Market Intelligence
An analysis of the operational shift from generative drafting to agentic workflow management. This report examines how AI-driven pacing and cognitive drag analysis are becoming critical infrastructure for risk mitigation in high-volume patent practices.

IP Insights
KIPO’s 2024 allowance rate reached 74.6%, but the average time to first office action stretched to 16.1 months. For applicants who can qualify, the 우선심사 (accelerated examination) track cuts that wait to roughly 6 months. The choice between ordinary and accelerated tracks now directly shapes portfolio cost, freedom-to-operate timelines, and the leverage a patentee holds before grant. Here is what the numbers say and what Korean and foreign filers should do with them.